D. L. Koble

Publications8
h-index4
Citations44
Highly Influential Citations0
Claim Author Page
Author pages are created from data sourced from our academic publisher partnerships and public sources.

Recommended Authors

  • J. Cannon
  • 390 Publications • 17,695 Citations
  • M. Gross
  • 804 Publications • 25,199 Citations
  • J. P. Long
  • 370 Publications • 3,802 Citations
  • T. Verimer
  • 18 Publications • 183 Citations
  • Publications
  • Influence
Derivatives of 5-hydroxy-6-methyl-2-aminotetralin.
TLDR
Three title compounds were designed to provide semirigid congeners of m-tyramine in which the ring position ortho to the phenolic OH is blocked to metabolic hydroxylation and were potent in a cat cardioaccelerator nerve assay, which involves dopamine receptors.
View on PubMed
Possible biologically active metabolites of 5-hydroxy-6-methyl-2-di-n-propylaminotetralin.
View on PubMed
Analysis of cyclodextrins using fast atom bombardment/mass spectrometry and tandem mass spectrometry
The combination of fast atom bombardment/mass spectrometry (FAB/MS) and FAB with tandem mass spectrometry (FAB/MS/MS) was used for the characterization of nearly 30 chemically modified cyclodextrins.…
View via Publisher
Metabolism and disposition of the dopaminergic agonist 5-hydroxy-6-methyl-2-di-n-propylaminotetralin in the rat.
TLDR
Data indicate that DK-118 is metabolized in the rat by a combination of N-dealkylation, oxidation of the 6-methyl carbon, and conjugation with sulfate, which indicates enterohepatic circulation of some of the drug/metabolites excreted in bile.
View on PubMed
Dopamine receptor stimulating activity of 5-hydroxy-6-methyl-2-aminotetralin derivatives.
TLDR
The results suggest that DK-121 and DK-118 possess stimulant properties on dopaminergic receptors in the central and peripheral nervous system, however,DK-121 does not appear to stimulate postsynaptic dopamine receptors inThe central nervous system.
View on PubMed
Synthesis of 5-hydroxy-[6-14C]-methyl-2-di-n-propylaminotetralin
By an improved synthesis, 5-hydroxy-6-methyl-2-di-n-propylaminotetralin (DK-118), a dopamine agonist, has been obtained in only six steps and in greater than 10% overall yield. This new synthesis has…
View via Publisher
Effects of metyrapone on the pharmacological activity, plasma levels and urinary excretion of the dopamine receptor agonist DK-118.
TLDR
Results of this study show that inhibition of DK-118 metabolism reduces certain of its pharmacologic actions, indicating that one or more of the metabolites of the drug may contribute to its effects.
View on PubMed
DERIVATIVES OF 5-HYDROXY-6-METHYL-2-AMINOTETRALIN
View via Publisher